Technical Update: Advancing the Global Health Security Agenda

Published : November 24, 2020

Controlling the global threat of antimicrobial resistance (AMR) relies on robust pharmaceutical systems worldwide that promote access to and appropriate use of medical products, including antimicrobial medicines, which is the core mission of the US Agency for International Development’s (USAID) Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program. Misuse and overuse of antimicrobials in humans and in animals is one of the leading causes of AMR. Containing and controlling the spread of AMR is particularly difficult in low- and middle-income countries (LMICs) due to weak infection prevention and control (IPC) measures and high rates of inappropriate use of antimicrobials facilitated by weak regulations, standards, systems, and governance.

Resource Type: Technical Briefs